Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node

NCT00297895 is registered in ClinicalTrials.gov with Saint John's Cancer Institute as lead sponsor.

NCT NCT00297895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node
Lead sponsor
Saint John's Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2004
Completion date
September 30, 2019
Enrollment
1,939 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma